In Wednesday’s Wall Street session, Boston Scientific Corp (NYSE:BSX) shares traded at $104.29, up 0.16% from the previous session.
BSX stock price is now 2.25% away from the 50-day moving average and 9.52% away from the 200-day moving average. The market capitalization of the company currently stands at $154.29B.
With the price target of $118, Leerink Partners recently initiated with Outperform rating for Boston Scientific Corp (NYSE: BSX). On April 16, 2025, Needham Upgraded its previous ‘Hold’ rating to ‘Buy’ on the stock keeping its target price maintained at $113, while ‘Deutsche Bank’ rates the stock as ‘Buy’
In other news, Fitzgerald Joseph Michael, EVP & Group Pres, Cardiology sold 56,372 shares of the company’s stock on Jun 04 ’25. The stock was sold for $5,799,630 at an average price of $102.88. Upon completion of the transaction, the EVP & Group Pres, Cardiology now directly owns 178,342 shares in the company, valued at $18.6 million. An SEC document containing details of the transaction can be found on the SEC’s website. On Jun 04 ’25, Officer JOSEPH M FITZGERALD bought 56,372 shares of the business’s stock. A total of $5,799,625 was incurred on buying the stock at an average price of $102.88. A total of 0.40% of the company’s stock is owned by insiders.
During the past 12 months, Boston Scientific Corp has had a low of $71.88 and a high of $107.17. As of last week, the company has a debt-to-equity ratio of 0.53, a current ratio of 1.45, and a quick ratio of 0.88. According to the stock market information, the enterprise value for the company is $165507465216, which is based on a 76.41 price-to-earnings ratio, a 5.43 price-to-earnings-growth ratio, and a beta of 0.68. The fifty day moving average price for BSX is $101.9998 and a two-hundred day moving average price translates $95.2264 for the stock.
The latest earnings results from Boston Scientific Corp (NYSE: BSX) was released for 2025-03-31. The net profit margin was 11.58% and return on equity was 9.65% for BSX. The company reported revenue of $4.66 billion for the quarter, compared to $3.86 billion a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue rose 20.93 percent. For the current quarter, analysts expect BSX to generate $4.89B in revenue.
